Search research articles
Contact Us
Filters
Showing results (301-310 of 443) with videos related to
Page
of 45
Sort By:
Hemasphere
|
April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party
Ali Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.
Blood
|
April 24, 2024
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT
Jaime Sanz, Myriam Labopin, Goda Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Roni Shouval, Myriam Labopin, Ori Bondi, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Haematologica
|
May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Arnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
Bone Marrow Transplantation
|
February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT
Jaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Haematologica
|
March 13, 2016
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
Bipin N Savani, Myriam Labopin, Nicolaus Kröger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2018
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study
Adrien Picod, Agnès Bonnin, Giorgia Battipaglia, et al.
Cancer
|
February 23, 2018
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center
Stefan O Ciurea, Myriam Labopin, Gerard Socie, et al.
Page
of 45
Search research articles
Search
Showing results (301-310 of 443) with videos related to
Sort By:
Page
of 45
Hemasphere
|
April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party
Ali Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.
Blood
|
April 24, 2024
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT
Jaime Sanz, Myriam Labopin, Goda Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Roni Shouval, Myriam Labopin, Ori Bondi, et al.
American Journal of Hematology
|
December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Haematologica
|
May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Arnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
Bone Marrow Transplantation
|
February 12, 2025
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT
Jaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Haematologica
|
March 13, 2016
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT
Bipin N Savani, Myriam Labopin, Nicolaus Kröger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2018
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study
Adrien Picod, Agnès Bonnin, Giorgia Battipaglia, et al.
Cancer
|
February 23, 2018
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center
Stefan O Ciurea, Myriam Labopin, Gerard Socie, et al.
Page
of 45